Scholars Central

Conference abstractPublished 25 Aug 2015

Extensive biochemical and structural studies to develop potent DNA topoisomerase II inhibitors as anticancer drugs

Authors: Somin Shin, Youngjoo Kwon

Ewha Womans University, Republic of Korea

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Human topoisomerases (topos) resolve DNA topological problems, unavoidably caused during DNA transcription, replication, recombination, and segregation of two identical copies of genomes in two daughter cells following replication. Topos can be grouped into two types according to the number of strands cleaved in one round of action. Topoisomerase type I (topo I) cleaves one strand of a DNA double helix while topoisomerase type II (topo II) cleaves both strands of one DNA duplex to make another noncleaved duplex pass through a transient, topo II-mediated break and then followed by reannealing the cleaved strands. Topo II is distinct from topo I in that topo II acts as a homodimer, requiring Mg (II) and ATP hydrolysis for enzyme turnover and rapid kinetics; this enables it to cut both DNA strands simultaneously. In addition, topo II is the only enzyme available to disentangle the topological problems in chromosomes, which must occur during DNA replication, and to decatenate the replicated chromosomes by introducing transient double strand breaks. Therefore, topo II has been targeted to develop chemotherapeutic drugs for long time. We have been studying to develop topo I- and/or topo II-targeting anticancer agents by synthesis of various flexible terpyridine derivatives with extensive biochemical evaluation and structural analysis. Our results are described in detail in this poster.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutical Care & Health Systems
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Somin Shin”
  • BylineArticles whose byline prints “Youngjoo Kwon”